Detail

Study ID: COG AGCT1532

Title:

AGCT1532, Phase 3 Accelerated BEP Trial: A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours

Location:
Sioux Falls Region
Principal Investigator:
Kayelyn Wagner, MD
Disease:
GCT (Germ Cell Tumor)
Stage:
Phase III
Status:
Active - Open to Accrual